RxNorm Semantic Concepts Index - 508
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "508".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 508 | 5-ureidohydantoin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 508 | 5-ureidohydantoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 508 | 5-ureidohydantoin | Designated preferred name (PT) | YES | |
| RxCUI: 508 | 5-ureidohydantoin | Full form of descriptor (FN) | YES | |
| RxCUI: 508 | 5-ureidohydantoin | Designated preferred name (PT) | YES | |
| RxCUI: 508 | 5-ureidohydantoin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 508 | 5-ureidohydantoin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 508 | 5-ureidohydantoin | Full form of descriptor (FN) | YES | |
| RxCUI: 50808 | Hemabate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 50823 | Heminevrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 50825 | Hemoglobin Boyle Heights | British preferred term (PTGB) | NO | |
| RxCUI: 50825 | Hemoglobin Boyle Heights | Designated preferred name (PT) | NO | |
| RxCUI: 50825 | Hemoglobin Boyle Heights | Full form of descriptor (FN) | NO | |
| RxCUI: 50826 | Hb 95(G2), Pro-ala | British preferred term (PTGB) | NO | |
| RxCUI: 50826 | Hb 95(G2), Pro-ala | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50826 | Hb 95(G2), Pro-ala | Designated preferred name (PT) | NO | |
| RxCUI: 50826 | Hb 95(G2), Pro-ala | Full form of descriptor (FN) | NO | |
| RxCUI: 50827 | Hb 22(B4), Glu-lys | British preferred term (PTGB) | NO | |
| RxCUI: 50827 | Hb 22(B4), Glu-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50827 | Hb 22(B4), Glu-lys | Designated preferred name (PT) | NO | |
| RxCUI: 50827 | Hb 22(B4), Glu-lys | Full form of descriptor (FN) | NO | |
| RxCUI: 50829 | Hb 103(G5), Phe-leu | British preferred term (PTGB) | NO | |
| RxCUI: 50829 | Hb 103(G5), Phe-leu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50829 | Hb 103(G5), Phe-leu | Designated preferred name (PT) | NO | |
| RxCUI: 50829 | Hb 103(G5), Phe-leu | Full form of descriptor (FN) | NO | |
| RxCUI: 50830 | Hb 46(CD5), Gly-glu | British preferred term (PTGB) | NO | |
| RxCUI: 50830 | Hb 46(CD5), Gly-glu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50830 | Hb 46(CD5), Gly-glu | Designated preferred name (PT) | NO | |
| RxCUI: 50830 | Hb 46(CD5), Gly-glu | Full form of descriptor (FN) | NO | |
| RxCUI: 50831 | Hb 47(CD6), Asp-tyr | British preferred term (PTGB) | NO | |
| RxCUI: 50831 | Hb 47(CD6), Asp-tyr | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50831 | Hb 47(CD6), Asp-tyr | Designated preferred name (PT) | NO | |
| RxCUI: 50831 | Hb 47(CD6), Asp-tyr | Full form of descriptor (FN) | NO | |
| RxCUI: 50832 | Hb 116(GH4), Glu-lys | British preferred term (PTGB) | NO | |
| RxCUI: 50832 | Hb 116(GH4), Glu-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50832 | Hb 116(GH4), Glu-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50832 | Hb 116(GH4), Glu-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50832 | Hb 116(GH4), Glu-lys | Designated preferred name (PT) | NO | |
| RxCUI: 50832 | Hb 116(GH4), Glu-lys | Full form of descriptor (FN) | NO | |
| RxCUI: 50835 | Hb 75(EF4), Asp-his | British preferred term (PTGB) | NO | |
| RxCUI: 50835 | Hb 75(EF4), Asp-his | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50835 | Hb 75(EF4), Asp-his | Designated preferred name (PT) | NO | |
| RxCUI: 50835 | Hb 75(EF4), Asp-his | Full form of descriptor (FN) | NO | |
| RxCUI: 50837 | Hb 96(FG3), Leu-val | British preferred term (PTGB) | NO | |
| RxCUI: 50837 | Hb 96(FG3), Leu-val | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50837 | Hb 96(FG3), Leu-val | Designated preferred name (PT) | NO | |
| RxCUI: 50837 | Hb 96(FG3), Leu-val | Full form of descriptor (FN) | NO | |
| RxCUI: 50839 | Hb 126(H9), Asp-his | British preferred term (PTGB) | NO | |
| RxCUI: 50839 | Hb 126(H9), Asp-his | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50839 | Hb 126(H9), Asp-his | Designated preferred name (PT) | NO | |
| RxCUI: 50839 | Hb 126(H9), Asp-his | Full form of descriptor (FN) | NO | |
| RxCUI: 5084 | Halcinonide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 5084 | Halcinonide | Designated preferred name (PT) | YES | |
| RxCUI: 5084 | Halcinonide | Full form of descriptor (FN) | YES | |
| RxCUI: 5084 | Halcinonide | Designated preferred name (PT) | YES | |
| RxCUI: 5084 | Halcinonide | Full form of descriptor (FN) | YES | |
| RxCUI: 50840 | Hb 141(HC3), Arg-pro | British preferred term (PTGB) | NO | |
| RxCUI: 50840 | Hb 141(HC3), Arg-pro | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50840 | Hb 141(HC3), Arg-pro | Designated preferred name (PT) | NO | |
| RxCUI: 50840 | Hb 141(HC3), Arg-pro | Full form of descriptor (FN) | NO | |
| RxCUI: 50841 | Hb 78(EF7), Asn-lys | British preferred term (PTGB) | NO | |
| RxCUI: 50841 | Hb 78(EF7), Asn-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50841 | Hb 78(EF7), Asn-lys | Designated preferred name (PT) | NO | |
| RxCUI: 50841 | Hb 78(EF7), Asn-lys | Full form of descriptor (FN) | NO | |
| RxCUI: 50844 | Hb 99(G1), Asp-tyr | British preferred term (PTGB) | NO | |
| RxCUI: 50844 | Hb 99(G1), Asp-tyr | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50844 | Hb 99(G1), Asp-tyr | Designated preferred name (PT) | NO | |
| RxCUI: 50844 | Hb 99(G1), Asp-tyr | Full form of descriptor (FN) | NO | |
| RxCUI: 50862 | Antigen of Hepacivirus C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50862 | Antigen of Hepacivirus C | Full form of descriptor (FN) | NO | |
| RxCUI: 50862 | Antigen of Hepacivirus C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 50862 | Antigen of Hepacivirus C | Designated preferred name (PT) | NO | |
| RxCUI: 50862 | Antigen of Hepacivirus C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 5088 | Hallucinogenic drug | Designated preferred name (PT) | NO | |
| RxCUI: 5088 | Hallucinogenic drug | Full form of descriptor (FN) | NO | |
| RxCUI: 5088 | Hallucinogenic drug | Designated preferred name (PT) | NO | |
| RxCUI: 5088 | Hallucinogenic drug | Full form of descriptor (FN) | NO | |
| RxCUI: 5088 | Hallucinogenic drug | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 5088 | Hallucinogenic drug | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |